PREVIOUS
✖
ZyCov – D
December 5 , 2021
966 days
575
0
- ZyCov - D is the second indigenous vaccine next to COVAXIN.
- The unique feature of ZyCov - D is that it is a needleless vaccine.
- At first, the ZyCov - D vaccine is to be launched in seven states.
- They are Tamil Nadu, Bihar, Maharashtra, Jharkhand, Punjab, West Bengal, and Uttar Pradesh.
- The vaccine is to be administered only to persons in the age group of 12 to 19 years.
- It is a three-dose vaccine.
- It is taken on the 28th day and the 56th day of the first dose.
- The ZyCov - D showed 66.6% efficacy.
- The vaccine was developed by the Indian Pharmaceutical company called Cadila Healthcare.
- The ZyCov - D vaccine was developed on plasmid DNA.
Leave a Reply
Your Comment is awaiting moderation.